These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 10518199)
21. Multifractionated dosing for cancer chemotherapy: a novel schedule and a work in progress. Lokich J Cancer Invest; 1999; 17(7):551-4. PubMed ID: 10518201 [No Abstract] [Full Text] [Related]
22. [Perspectives of improvement of chemotherapy effectiveness in disseminated solid tumors]. Sivashinskiĭ MS Vopr Onkol; 2004; 50(2):237-42. PubMed ID: 15176230 [No Abstract] [Full Text] [Related]
23. [Organ-preserving treatment of bladder cancer with combined radiochemotherapy: Do patients profit from additional neoadjuvant chemotherapy?]. Diestelhorst A; Dunst J Strahlenther Onkol; 1999 Aug; 175(8):414-5. PubMed ID: 10481776 [No Abstract] [Full Text] [Related]
24. How strong is the case for intensive cancer chemotherapy? Tattersall MH; Tobias JS Lancet; 1976 Nov; 2(7994):1071-2. PubMed ID: 62911 [No Abstract] [Full Text] [Related]
25. Drug dosage intensity--a panel discussion. McGuire WL; Goldie J; Hryniuk W; Tormey DC Breast Cancer Res Treat; 1987; 9(2):87-100. PubMed ID: 3620720 [TBL] [Abstract][Full Text] [Related]
27. Reinforcement learning-based control of drug dosing for cancer chemotherapy treatment. Padmanabhan R; Meskin N; Haddad WM Math Biosci; 2017 Nov; 293():11-20. PubMed ID: 28822813 [TBL] [Abstract][Full Text] [Related]
28. Will increases in dose intensity improve outcome: con. Souhami RL Am J Med; 1995 Dec; 99(6A):71S-76S. PubMed ID: 8585544 [No Abstract] [Full Text] [Related]
29. Algorithms for scheduling of chemotherapy plans. Sevinc S; Sanli UA; Goker E Comput Biol Med; 2013 Dec; 43(12):2103-9. PubMed ID: 24290927 [TBL] [Abstract][Full Text] [Related]
30. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. Chlebowski RT J Natl Cancer Inst; 2010 Jan; 102(2):137. PubMed ID: 20019336 [No Abstract] [Full Text] [Related]
32. The importance of dose and schedule in cancer chemotherapy: breast cancer. Leonard RC Anticancer Drugs; 1995 Oct; 6 Suppl 5():17-27. PubMed ID: 8845492 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose? Schuchter LM J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612 [No Abstract] [Full Text] [Related]
34. Intraperitoneal chemotherapy in the management of malignant disease. Markman M Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122 [TBL] [Abstract][Full Text] [Related]
39. [Chronochemotherapy for cancer]. Akazawa S Gan To Kagaku Ryoho; 1997 Aug; 24(10):1191-202. PubMed ID: 9279336 [TBL] [Abstract][Full Text] [Related]
40. [A combination phase I/II study--dose escalation plan]. Yamamoto N Gan To Kagaku Ryoho; 2000 Dec; 27(14):2267-74. PubMed ID: 11142175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]